Cerebrospinal fluid light neurofilaments as a therapeutic marker of response in modifying therapies disease in multiple sclerosis

被引：0
|
作者：
Gomez, Fabian [1 ]
Oehninger, Carlos [1 ]
机构：
[1] Fac Med, Hosp Clin, Montevideo, Uruguay
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.055
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
645
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] Serum and cerebrospinal fluid antibodies against the light subunit of neurofilaments in multiple sclerosis
    Bartos, A.
    Fialova, L.
    Soukupova, J.
    Malbohan, I.
    Kukal, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 14 - 14
  • [2] Cerebrospinal fluid neurofilament light chain is a marker of disease activity in multiple sclerosis
    Poletto, E.
    Zanoni, M.
    Bongianni, M.
    Turatti, M.
    Calabrese, M.
    Marangi, A.
    Gobbin, F.
    Monaco, S.
    Benedetti, D.
    Gajofatto, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 290 - 291
  • [3] RESPONSE TO DISEASE MODIFYING THERAPIES IN AFRICAN AMERICANS WITH MULTIPLE SCLEROSIS
    Klineova, Sylvia
    Nicholas, Joyce
    Walker, Aljoeson
    [J]. ETHNICITY & DISEASE, 2012, 22 (02) : 221 - 225
  • [4] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [5] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    [J]. NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [6] Iatrogenesis in multiple sclerosis: what is the therapeutic risk of our disease modifying therapies?
    Roman, C.
    Power, D.
    Kutz, C.
    West, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 777 - 778
  • [7] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    [J]. NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [8] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [9] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    [J]. NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [10] RANKING OF DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A750 - A750
12345